v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Collaboration revenue $ 0 $ 959 $ 0 $ 2,877
Operating expenses:        
Research and development 36,226 30,227 68,547 69,001
General and administrative 10,511 13,219 17,861 21,171
Change in fair value of contingent consideration 8,733 (566) 8,842 (6,214)
Total operating expenses 55,470 42,880 95,250 83,958
Operating loss (55,470) (41,921) (95,250) (81,081)
Other income (expense), net:        
Interest income 2,832 872 4,540 2,028
Interest expense (20) (2) (30) (4)
Other expense, net (138) (154) (255) (443)
Total other income, net 2,674 716 4,255 1,581
Loss before income taxes (52,796) (41,205) (90,995) (79,500)
Income tax provision (8) 30 55 170
Net loss (52,788) (41,235) (91,050) (79,670)
Other comprehensive (loss) income:        
Foreign currency translation adjustment 113 1,314 (193) 1,889
Unrealized gain (loss) on marketable securities, net of tax (471) 5 (557) (5)
Total other comprehensive (loss) income (358) 1,319 (750) 1,884
Comprehensive loss (53,146) (39,916) (91,800) (77,786)
Net loss attributable to common stockholders (see Note 15) $ (52,788) $ (41,235) $ (91,050) $ (79,670)
Net loss per share attributable to common stockholders, basic $ (1.74) $ (29.54) $ (5.05) $ (67.11)
Net loss per share attributable to common stockholders, diluted $ (1.74) $ (29.54) $ (5.05) $ (67.11)
Weighted-average common stock outstanding, basic [1] 30,277,051 1,395,695 18,034,399 1,187,080
Weighted-average common stock outstanding, diluted [1] 30,277,051 1,395,695 18,034,399 1,187,080
[1] The weighted-average number of common shares used in computing net loss basic and diluted per share for the three and six months ended June 30, 2025 includes 4,056,164 shares of common stock underlying Common Warrants issued as part of the Series D preferred stock financing during 2025.